Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
Sponsor: New Mexico Cancer Research Alliance • ClinicalTrials.gov ID: NCT06207864
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
This clinical trial studies engagement strategies for recruiting American Indians (AI) of Southwestern Tribal Nations for cancer genome sequencing. American Indians in the Southwest have higher rates of some types of cancer, such as cancers that arise in the liver, kidney, breast, and colon. American Indians with cancer may also live for less time than people from other population groups who have been treated for the same cancer. Damage to the cells of the body, acquired as people live, grow older, and are exposed to the environment, causes genetic changes in cells that can lead to cancer. This study may help researchers learn how these genetic changes in cells cause cancer and understand how and why cancer is arising in American Indians in the Southwest. This may help better prevent and treat cancer in the future.
Interventions
-
Biospecimen Collection
(Procedure)
Undergo collection of tissue, blood, saliva, and stool samples
-
Return of Results
(Procedure)
Receive results
-
Survey Administration
(Other)
Surveys and Interviews
Eligibility criteria
Conditions
Locations
- University of New Mexico Comprehensive Cancer Center — Albuquerque, New Mexico, United States
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record